The global pharmaceutical excipients market is expected to grow from US$ 7.97 billion in 2023 to US$ 12.61 billion by 2030, at a CAGR of 5.9%. This growth is being driven by a number of factors, including the increasing demand for oral pharmaceutical medicines, the rising prevalence of chronic diseases, and the growing development of novel therapeutics.

Pharmaceutical excipients are inert substances that are included in the production process or are present in pharmaceutical product dosage format. They play a vital role in ensuring the safety, efficacy, and stability of pharmaceutical products. Excipients can be used to improve the solubility, dissolution, and bioavailability of active pharmaceutical ingredients (APIs). They can also be used to mask unpleasant tastes and odors, improve the appearance of products, and extend their shelf life.

Pharmaceutical excipients are inert substances that are added to drugs and other pharmaceuticals to improve their delivery, stability, and efficacy. They play a vital role in the development and formulation of pharmaceuticals, but they are often overlooked.

Get Recently Updated Report of Market as Sample Copy! https://bit.ly/45US9sn

Growth Drivers:

The major growth drivers of the global pharmaceutical excipients market include:

  • The increasing demand for oral pharmaceutical medicines: Oral solid drugs are the most commonly prescribed and consumed dosage form of pharmaceuticals. This is due to their ease of administration and convenience. As a result, the demand for pharmaceutical excipients used in oral solid formulations is also expected to grow.
  • The growing prevalence of chronic diseases: The prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is increasing globally. These diseases require long-term treatment, which drives the demand for pharmaceutical excipients used in chronic disease medications.
  • The rising number of new drug approvals: The number of new drug approvals has been increasing in recent years. This is due to the advancements in pharmaceutical research and development. The development of new drugs creates new opportunities for the pharmaceutical excipients market.
  • The increasing focus on developing novel drug delivery systems: Pharmaceutical companies are increasingly focusing on developing novel drug delivery systems to improve the efficacy and safety of drugs. These novel drug delivery systems often require specialized excipients. As a result, the demand for pharmaceutical excipients used in novel drug delivery systems is expected to grow.

Key Takeaways:

  • The global pharmaceutical excipients market is expected to grow from US$ 7.97 billion in 2023 to reach US$ 12.61 billion by 2030, growing at a CAGR of 5.9% from 2023 to 2030.
  • The increasing prevalence of chronic diseases, the rising demand for generic drugs, and the growing investments in R&D are the key factors driving the growth of the market.
  • North America is expected to remain the largest market for pharmaceutical excipients during the forecast period, followed by Europe and Asia Pacific.
  • The major players in the pharmaceutical excipients market include Ashland Global Holdings Inc., BASF SE, Dow Chemical Company, Evonik Industries AG, Lonza Group Ltd., Merck KGaA, and Roquette Frères.

Regional Outlook:

North America is expected to remain the largest market for pharmaceutical excipients during the forecast period. This is due to the presence of a large number of pharmaceutical companies and the high demand for high-quality excipients in the region. Europe is expected to be the second-largest market, followed by Asia Pacific. The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, due to the increasing prevalence of chronic diseases and the rising demand for generic drugs in the region.

Key Players:

The major players in the pharmaceutical excipients market include:

  • Ashland Global Holdings Inc.
  • BASF SE
  • Dow Chemical Company
  • Evonik Industries AG
  • Lonza Group Ltd.
  • Merck KGaA
  • Roquette Frères

These companies offer a wide range of pharmaceutical excipients, including binders, disintegrants, fillers and diluents, lubricants and glidants, and others.

Segmentation:

The global pharmaceutical excipients market is segmented by type, application, and region.

By type, the market is segmented into:

  • Organic excipients
  • Inorganic excipients

By application, the market is segmented into:

  • Fillers and diluents
  • Suspending and viscosity agents
  • Coating agents
  • Binders
  • Flavoring agents and sweeteners
  • Disintegrants
  • Colorants
  • Lubricants and glidants
  • Preservatives
  • Emulsifying agents
  • Other functionalities

By region, the market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa